Gaborone — The Ministry of Health has initiated measures to address the unusual rise of Tuberculosis (TB) treatment failure.
In a press release, the ministry notes that the specific batch of the TB drugs with the poor outcomes were quarantined and taken for testing.
The results shows that the concerned Fixed Dose Combination (FDC) drugs are deficient of two critical anti-TB molecules: Rifampicin and Ethambutol.
Keep up with the latest headlines on WhatsApp | LinkedIn
Although it is…
Read more on AllAfrica.com
South Africa Today Africa – Southern Africa Botswana News























